Baidu
map

风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

全身型幼年特发性关节炎诊断与治疗中国专家共识（2019年版）

2019-12-30 中国医师协会儿科医师分会风湿免疫专业委员会 中国实用儿科杂志.2019,34 (12):969-976.

全身型幼年特发性关节炎

SJIA 为异质性疾病，对起病时全身症状突出而缺乏关节炎证据、后期有明显侵蚀性关节炎而缺乏全身症状以及单峰型疾病过程等不同病程的认识，需要不断完善和进一步验证研究。虽然本共识还存在不足和局限性，但希望能在此基础上，经过3～5年的工作，能得出我们自己的、有循证依据的SJIA诊疗专家共识，从而推动我国SJIA诊治能力进一步提高。

中文标题：

全身型幼年特发性关节炎诊断与治疗中国专家共识（2019年版）

发布机构：

中国医师协会儿科医师分会风湿免疫专业委员会

发布日期：

2019-12-30

简要介绍：

SJIA 为异质性疾病，对起病时全身症状突出而缺乏关节炎证据、后期有明显侵蚀性关节炎而缺乏全身症状以及单峰型疾病过程等不同病程的认识，需要不断完善和进一步验证研究。虽然本共识还存在不足和局限性，但希望能在此基础上，经过3～5年的工作，能得出我们自己的、有循证依据的SJIA诊疗专家共识，从而推动我国SJIA诊治能力进一步提高。

 

拓展指南：与关节炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=全身型幼年特发性关节炎诊断与治疗中国专家共识（2019年版）)] GetToolGuiderByIdResponse(projectId=1, id=72aa51c0018e0769, title=全身型幼年特发性关节炎诊断与治疗中国专家共识（2019年版）, enTitle=, guiderFrom=中国实用儿科杂志.2019,34 (12):969-976., authorId=null, author=, summary=SJIA 为异质性疾病，对起病时全身症状突出而缺乏关节炎证据、后期有明显侵蚀性关节炎而缺乏全身症状以及单峰型疾病过程等不同病程的认识，需要不断完善和进一步验证研究。虽然本共识还存在不足和局限性，但希望能在此基础上，经过3～5年的工作，能得出我们自己的、有循证依据的SJIA诊疗专家共识，从而推动我国SJIA诊治能力进一步提高。 , cover=, journalId=null, articlesId=null, associationId=1884, associationName=中国医师协会儿科医师分会风湿免疫专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Dec 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>SJIA 为异质性疾病，对起病时全身症状突出而缺乏关节炎证据、后期有明显侵蚀性关节炎而缺乏全身症状以及单峰型疾病过程等不同病程的认识，需要不断完善和进一步验证研究。虽然本共识还存在不足和局限性，但希望能在此基础上，经过3～5年的工作，能得出我们自己的、有循证依据的SJIA诊疗专家共识，从而推动我国SJIA诊治能力进一步提高。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>关节炎</FONT>相关指南：</STRONG><BR> <UL> <LI><A title="2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=142071c001860069">2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎</A> <LI><A title="2020 ILAR建议：资源贫乏地区银屑病关节炎的管理" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=0f3cd1c001855313">2020 ILAR建议：资源贫乏地区银屑病关节炎的管理</A> <LI><A title="2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=a156c1c00185a0c7">2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理</A> <LI><A title="2019 台湾临床实践建议：影像学检查在中轴型脊柱关节炎的诊断和管理中的应用" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=d20f51c0018a316c">2019 台湾临床实践建议：影像学检查在中轴型脊柱关节炎的诊断和管理中的应用</A> <LI><A title=锝[99Tc]亚甲基二膦酸盐注射液治疗类风湿关节炎专家共识 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=98ad71c001829146">锝[99Tc]亚甲基二膦酸盐注射液治疗类风湿关节炎专家共识</A> 更多信息请点击：<A target=_blank href="//m.capotfarm.com/guideline/list.do?q=%E5%85%B3%E8%8A%82%E7%82%8E">有关关节炎更多指南</A></LI></UL>, tagList=[TagDto(tagId=64537, tagName=全身型幼年特发性关节炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11774, appHits=351, showAppHits=34, pcHits=2567, showPcHits=10815, likes=8, shares=45, comments=8, approvalStatus=1, publishedTime=Sat Feb 29 23:02:22 CST 2020, publishedTimeString=2019-12-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Feb 29 23:02:22 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:19:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=全身型幼年特发性关节炎诊断与治疗中国专家共识（2019年版）)])
全身型幼年特发性关节炎诊断与治疗中国专家共识（2019年版）
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191369, encodeId=6e8511913699a, content=欧克, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0NwvDHRNlqa111AoXEr9gJwLafxiayhnwibibrxCcA59Zy3DMHDyfiah87TuTrp4h8oAPyniczvF9Dow/132, createdBy=0a991951729, createdName=zhaowenjia, createdTime=Wed Feb 09 10:39:37 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067832, encodeId=04e2106e832fb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86cf5607631, createdName=ms2000001964837779, createdTime=Sun Nov 07 17:33:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055368, encodeId=c233105536818, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 14:48:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968302, encodeId=ac3a968302c0, content=指导性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Tue May 25 03:47:38 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912027, encodeId=33db91202e3f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d72489528, createdName=124764c3m24(暂无昵称), createdTime=Wed Dec 30 00:46:37 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2022-02-09 zhaowenjia

    欧克

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191369, encodeId=6e8511913699a, content=欧克, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0NwvDHRNlqa111AoXEr9gJwLafxiayhnwibibrxCcA59Zy3DMHDyfiah87TuTrp4h8oAPyniczvF9Dow/132, createdBy=0a991951729, createdName=zhaowenjia, createdTime=Wed Feb 09 10:39:37 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067832, encodeId=04e2106e832fb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86cf5607631, createdName=ms2000001964837779, createdTime=Sun Nov 07 17:33:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055368, encodeId=c233105536818, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 14:48:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968302, encodeId=ac3a968302c0, content=指导性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Tue May 25 03:47:38 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912027, encodeId=33db91202e3f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d72489528, createdName=124764c3m24(暂无昵称), createdTime=Wed Dec 30 00:46:37 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2021-11-07 ms2000001964837779

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191369, encodeId=6e8511913699a, content=欧克, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0NwvDHRNlqa111AoXEr9gJwLafxiayhnwibibrxCcA59Zy3DMHDyfiah87TuTrp4h8oAPyniczvF9Dow/132, createdBy=0a991951729, createdName=zhaowenjia, createdTime=Wed Feb 09 10:39:37 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067832, encodeId=04e2106e832fb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86cf5607631, createdName=ms2000001964837779, createdTime=Sun Nov 07 17:33:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055368, encodeId=c233105536818, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 14:48:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968302, encodeId=ac3a968302c0, content=指导性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Tue May 25 03:47:38 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912027, encodeId=33db91202e3f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d72489528, createdName=124764c3m24(暂无昵称), createdTime=Wed Dec 30 00:46:37 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2021-09-27 13f0c37dm61暂无昵称

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191369, encodeId=6e8511913699a, content=欧克, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0NwvDHRNlqa111AoXEr9gJwLafxiayhnwibibrxCcA59Zy3DMHDyfiah87TuTrp4h8oAPyniczvF9Dow/132, createdBy=0a991951729, createdName=zhaowenjia, createdTime=Wed Feb 09 10:39:37 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067832, encodeId=04e2106e832fb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86cf5607631, createdName=ms2000001964837779, createdTime=Sun Nov 07 17:33:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055368, encodeId=c233105536818, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 14:48:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968302, encodeId=ac3a968302c0, content=指导性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Tue May 25 03:47:38 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912027, encodeId=33db91202e3f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d72489528, createdName=124764c3m24(暂无昵称), createdTime=Wed Dec 30 00:46:37 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2021-05-25 1463eea1m97暂无昵称

    指导性强

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191369, encodeId=6e8511913699a, content=欧克, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0NwvDHRNlqa111AoXEr9gJwLafxiayhnwibibrxCcA59Zy3DMHDyfiah87TuTrp4h8oAPyniczvF9Dow/132, createdBy=0a991951729, createdName=zhaowenjia, createdTime=Wed Feb 09 10:39:37 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067832, encodeId=04e2106e832fb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86cf5607631, createdName=ms2000001964837779, createdTime=Sun Nov 07 17:33:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055368, encodeId=c233105536818, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 14:48:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968302, encodeId=ac3a968302c0, content=指导性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Tue May 25 03:47:38 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912027, encodeId=33db91202e3f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d72489528, createdName=124764c3m24(暂无昵称), createdTime=Wed Dec 30 00:46:37 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2020-12-30 124764c3m24(暂无昵称)

    学习

    0

Baidu
map
Baidu
map
Baidu
map